文献速递主动脉疾病外周动脉疾病

替代主动脉支架主髂动脉重建用于髂动脉分支支架的可行性与安全性

Alternative Endograft Aortoiliac Reconstruction for Iliac Branch Endoprostheses.
PubMed 文献 · Ann Vasc Surg · 2021-08-26

本研究纳入7例因主髂动脉解剖条件不符合现行髂动脉分支支架(IBE)说明书要求而无法常规部署的复杂髂动脉瘤患者,采用Endologix AFX、Ovation limbs或Medtronic Endurant II平台行替代主动脉支架主髂动脉重建(AEGAR)。所有患者技术成功且无围术期并发症,随访期间动脉瘤稳定或缩小、支架通畅、无内漏或移位。

要点

  • AEGAR技术可安全有效地克服妨碍现行IBE部署的主髂动脉解剖限制。
  • 7例患者全部技术成功,无围术期并发症,平均住院2.2天。
  • 随访82-957天,动脉瘤稳定或缩小,无内漏或移位。

核心结论

  • AEGAR技术可安全有效地克服某些妨碍现行IBE技术使用的主髂动脉解剖限制。
  • 鼓励在相关解剖构型中更广泛地使用这些替代支架。

研究设计与样本

  • 单中心连续病例系列,纳入7例CIA或IIA动脉瘤患者。
  • 因近端CIA锚定区不足(n=7)、肾动脉至髂动脉分叉长度不足(n=2)、主动脉解剖不佳(n=3)或肾下颈短于15 mm(n=1)等解剖条件不符合IBE说明书要求。
  • 采用Endologix AFX、Endologix Ovation limbs或Medtronic Endurant II平台行AEGAR技术,IIA重建和EIA延伸使用Gore VBX或Viabahn支架。

主要发现

  • 平均年龄69岁(范围52-82岁),6例男性。
  • 4例双侧CIA动脉瘤,3例单侧CIA动脉瘤,平均直径4.3 cm(范围2.2-7 cm)。
  • 共使用13枚IIA VBX支架治疗9条IIA(2例双侧IBE)。
  • 平均透视时间38.8分钟(范围21.3-64.3分钟),平均对比剂用量168.5 mL(范围122-226 mL)。
  • 全部患者技术成功,无围术期并发症,平均住院2.2天(范围1-3天)。

关键数值与推荐

  • 技术成功定义为所有支架组件成功释放且无移位或内漏,本组技术成功率为全部患者。
  • IBE说明书要求使用相应制造商的模块化分叉主动脉支架,且近端CIA锚定区充足、肾动脉至髂动脉分叉长度足够、主动脉解剖适合、肾下颈≥15 mm。

临床怎么用

  • 对于因近端CIA锚定区不足、肾动脉至髂动脉分叉长度不足、主动脉解剖不佳或肾下颈短于15 mm而不符合IBE说明书要求的复杂髂动脉瘤患者,可考虑采用AEGAR技术。
  • AEGAR技术使用Endologix AFX、Endologix Ovation limbs或Medtronic Endurant II平台进行主髂动脉重建,以促进IBE部署。

局限性

  • 样本量小(7例),随访时间有限(最长957天)。
  • 单中心、回顾性设计,缺乏对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular treatment of complex common iliac artery (CIA) and internal iliac artery (IIA) aneurysms using iliac branch endoprostheses (IBE) has proven safe and effective. Instructions for use (IFU) require deployment of current IBE technology with the corresponding manufacturer's modular bifurcated aortic endograft. Concomitant aortoiliac occlusive disease, inadequate renal artery-iliac bifurcation length, and unfavorable aortic anatomy preclude on-label IBE deployment. This study aimed to evaluate the technical feasibility and safety of Alternative Endograft Aortoiliac Reconstruction (AEGAR) for branched endovascular treatment of complex iliac artery aneurysms. METHODS: In 7 consecutive patients with CIA or IIA aneurysms, computed tomography angiography (CTA) and center-line reconstruction revealed aortoiliac anatomy incompatible with the current IBE IFU due to inadequate proximal CIA landing zone (n = 7), inadequate renal artery to iliac bifurcation length (n = 2), compromised aortic anatomy (n = 3), or short infrarenal neck <15 mm (n = 1), either alone or in combination. To overcome these restrictions and facilitate IBE deployment, aortoiliac reconstruction was performed using the Endologix AFX, Endologix Ovation limbs or the Medtronic Endurant II platforms (AEGAR technique). All internal iliac artery reconstructions and external iliac artery extensions were performed using the Gore VBX or Viabahn stent grafts. Technical success was defined as successful delivery of all endograft components without migration or endoleak. RESULTS: The mean patient age was 69 years (range 52-82 years; 6 male). Four patients had bilateral CIA aneurysms and 3 patients had unilateral CIA aneurysms (mean diameter 4.3cm; range 2.2-7 cm). There were 13 IIA VBX stent grafts used for a total of 9 IIAs treated with IBE (bilateral IBE = 2 patients). The mean fluoroscopy time was 38.8 min (range 21.3-64.3 min) and the mean contrast volume was 168.5 mL (range 122-226 mL). Technical success was achieved in all patients and there were no perioperative complications. Mean hospital-stay was 2.2 days (range 1-3 days). Follow-up ranged from 82-957 days (mean = 487 days). At last follow-up, all patients were alive without cardiovascular morbidity; and CTA revealed stable or decreased aneurysm size, patent endografts, and no evidence of endoleak or migration. CONCLUSIONS: The AEGAR technique can be used to safely and effectively overcome certain aortoiliac anatomic constraints that preclude use of current IBE technology. We encourage broader use of these alternative endografts in pertinent anatomic configurations.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Brahmandam A, Chen JF, Tonnessen BH, et al. Alternative Endograft Aortoiliac Reconstruction for Iliac Branch Endoprostheses. Ann Vasc Surg. 2021. PMID: 34455041. doi:10.1016/j.avsg.2021.05.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。